Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed
Conditions studied: Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia
In brief
This is a multi-center trial for rasburicase in children at high risk of tumor lysis syndrome who have a history of asthma/atopy. The main purpose of this study is to establish the safety of this drug in patients with a history of asthma or severe allergies.
Key facts
- Study ID
- NCT00186940
- Run by
- St. Jude Children's Research Hospital
- People needed
- 16
- Starts
- 2005-03-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2017-04-25
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A diagnosis of hematologic malignancy.
- Existing hyperuricemia or high risk of developing hyperuricemia of malignancy.
- The treating clinician plans to treat the patient with rasburicase. A patient is only eligible for RASALL if the clinician has already decided to use rasburicase. Rasburicase should not be given in order to make a patient eligible for this non-therapeutic observational study.
- No prior exposure to rasburicase or other urate oxidase.
- A history of asthma or significant allergy.
You may not qualify if…
- Wheezing or an active hypersensitivity reaction at entry.
- Hypersensitivity to Aspergillus proteins.
Where it is running
- Stanford University — Palo Alto, California, United States
- Rady Children's Hospital — San Diego, California, United States
- Peyton Manning Children's Hospital at St. Vincent — Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Children's Hospital Michigan — Detroit, Michigan, United States
- Columbia University Medical Center — New York, New York, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- St.Jude Children's Research Hospital — Memphis, Tennessee, United States
- Cook Children's Medical Center — Fort Worth, Texas, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Mid-West Children's Cancer Center — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.